Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

151 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Targeted T cell receptor gene editing provides predictable T cell product function for immunotherapy.
Müller TR, Jarosch S, Hammel M, Leube J, Grassmann S, Bernard B, Effenberger M, Andrä I, Chaudhry MZ, Käuferle T, Malo A, Cicin-Sain L, Steinberger P, Feuchtinger T, Protzer U, Schumann K, Neuenhahn M, Schober K, Busch DH. Müller TR, et al. Among authors: steinberger p. Cell Rep Med. 2021 Aug 17;2(8):100374. doi: 10.1016/j.xcrm.2021.100374. eCollection 2021 Aug 17. Cell Rep Med. 2021. PMID: 34467251 Free PMC article.
Engineered soluble, trimerized 4-1BBL variants as potent immunomodulatory agents.
Battin C, De Sousa Linhares A, Leitner J, Grossmann A, Lupinek D, Izadi S, Castilho A, Waidhofer-Söllner P, Grabmeier-Pfistershammer K, Stritzker J, Steinberger P. Battin C, et al. Among authors: steinberger p. Cancer Immunol Immunother. 2023 Sep;72(9):3029-3043. doi: 10.1007/s00262-023-03474-8. Epub 2023 Jun 13. Cancer Immunol Immunother. 2023. PMID: 37310433 Free PMC article.
Bet v 1-specific T-cell receptor/forkhead box protein 3 transgenic T cells suppress Bet v 1-specific T-cell effector function in an activation-dependent manner.
Schmetterer KG, Haiderer D, Leb-Reichl VM, Neunkirchner A, Jahn-Schmid B, Küng HJ, Schuch K, Steinberger P, Bohle B, Pickl WF. Schmetterer KG, et al. Among authors: steinberger p. J Allergy Clin Immunol. 2011 Jan;127(1):238-45, 245.e1-3. doi: 10.1016/j.jaci.2010.10.023. J Allergy Clin Immunol. 2011. PMID: 21211658
TIM-3 does not act as a receptor for galectin-9.
Leitner J, Rieger A, Pickl WF, Zlabinger G, Grabmeier-Pfistershammer K, Steinberger P. Leitner J, et al. Among authors: steinberger p. PLoS Pathog. 2013 Mar;9(3):e1003253. doi: 10.1371/journal.ppat.1003253. Epub 2013 Mar 21. PLoS Pathog. 2013. PMID: 23555261 Free PMC article.
TIM-3 and CEACAM1 do not interact in cis and in trans.
De Sousa Linhares A, Kellner F, Jutz S, Zlabinger GJ, Gabius HJ, Huppa JB, Leitner J, Steinberger P. De Sousa Linhares A, et al. Among authors: steinberger p. Eur J Immunol. 2020 Aug;50(8):1126-1141. doi: 10.1002/eji.201948400. Epub 2020 Apr 28. Eur J Immunol. 2020. PMID: 32222966 Free PMC article.
151 results